Skip to main content
. 2022 Feb 23;37(1):768–780. doi: 10.1080/14756366.2022.2036737

Figure 3.

Figure 3.

In vitro anti-neuroinflammatory activity in BV2 Cells: A) dose-dependent effects of compounds 1p and 1y as well as safinamide and hispidol against LPS-induced production of nitric oxide; B) Dose-dependent effects of compounds 1p and 1y as well as safinamide and hispidol against LPS-induced production of PGE2.